Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : biotech firesales -- Ignore unavailable to you. Want to Upgrade?

To: fred hayes who wrote (2770)	2/2/2011 11:28:58 AM
From: scaram(o)uche	Read Replies (1) \| Respond to of 3661

Hi, Fred. I expect the middle dose (46 mg topiramate) to have a good chance of approval, a better shot than your 20 or 40%.... picking a number, I guess I'll go for 70%. There should be plenty of patients who got pregnant while taking top for migraine prophylaxis? Patients, as you know, take higher doses (200-400 mg daily and higher) of top for epilepsy. And they appear to have issues with drug-drug interaction, re. frequency of clefts? We will see. Rick